Equity markets commerce decrease dragged by pharma shares, relentless overseas fund outflows

Equity benchmark indices Sensex and Nifty declined in early commerce on Friday (September 26, 2025) dragged by pharma shares and relentless overseas fund outflows.

U.S. H-1B visa charge considerations and a weak development in world markets additionally added to the bearish development in home equities.

“Investor attention will squarely be on the domestic pharma sector after the Trump Administration announced a 100 per cent tariff on imports of branded or patented pharmaceutical products effective October 1. This tariff action comes close on the heels of the steep hike in US H-1B visa fees, which has already triggered heavy selling in IT sector stocks over the past few sessions,” Ponmudi R, CEO of Enrich Money, a web-based buying and selling and wealth tech agency, stated.

The 30-share BSE Sensex declined 329.66 factors to 80,830.02 in early commerce. The 50-share NSE Nifty dropped 105.7 factors to 24,785.15.

From the Sensex corporations, Sun Pharma dropped over 3%. Asian Paints, Tech Mahindra, Infosys, Power Grid, HCL Tech, and Tata Steel have been additionally among the many laggards.

However, Larsen & Toubro, Tata Motors, ITC and Trent have been the gainers.

In Asian markets, South Korea’s Kospi, Japan’s Nikkei 225 index, Shanghai’s SSE Composite index and Hong Kong’s Hang Seng quoted decrease.

U.S. markets ended decrease on Thursday.

Foreign Institutional Investors (FIIs) offloaded equities value ₹4,995.42 crore on Thursday, in line with change knowledge.

“The sustained FII selling may keep the market under pressure,” V Ok Vijayakumar, Chief Investment Strategist, Geojit Investments Ltd, stated.

Global oil benchmark Brent crude climbed 0.17% to $69.54 a barrel.

On Thursday (September 25, 2025), the Sensex tanked 555.95 factors or 0.68% to settle at 81,159.68. The Nifty tumbled 166.05 factors or 0.66% to 24,890.85.